Tag Archives: More

Glaxo's ViiV touts more two-drug HIV success with monthly injectable win

GlaxoSmithKline’s ViiV Healthcare has already shown that a two-drug HIV regimen can hang with its three-drug competitors. But now it has data showing it can do the same with administration just once per month. Thursday, ViiV rolled out results from two studies showing an injection pairing its own cabotegravir with Johnson & Johnson’s rilpivirine (Edurant), given once every four… Read More »

Younger patients dissatisfied with healthcare's status quo, more willing to try nontraditional services

Healthcare consumers are changing, and their expectations are changing, too. They want convenience, affordability and quality, and younger patients especially are dissatisfied with the status quo and more likely to adopt nontraditional healthcare, such as virtual care and retail clinics. According to a new Accenture survey, consumers of all ages are showing more willingness to… Read More »